Stay updated with breaking news from Agvhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bonnie Dirr, APRN, introduces a clinical scenario of a patient who received an allogeneic stem cell transplant from a sibling donor to begin the panel’s discussion of graft versus host disease.
Mahasweta Gooptu, MD, reviews statistics on graft versus host disease and explains the desired graft versus leukemia effect.
Exploring FDA-approved treatment options for patients with chronic GvHD, with a focus on trial data and adverse effects.
Insights on treatment strategies and goals for initial chronic GvHD management, including treatment selection rationale and dosing.
Experienced clinicians discuss the future of acute GvHD treatment, focusing on gaps in patient care and potential therapy options.